If you have been researching weight loss medications in Canada, you have probably come across Wegovy. It made headlines as a "game changer" and for good reason. But there is a lot of confusion about what Wegovy actually is, how it differs from Ozempic, and whether you can even get it in Canada right now. I wrote this guide to cut through the noise and give you the real picture based on clinical data and the Canadian healthcare landscape.
Wegovy is the weight loss version of semaglutide. Same molecule as Ozempic, different dose, different approval. This page covers everything specific to Wegovy, including the trial data, dosing schedule, and what to realistically expect. For deeper dives on cost, side effects, or how to get a prescription, I have linked out to dedicated pages.
What Makes Wegovy Different From Ozempic?
This is the most common question I get, and the answer is simpler than you might think. Wegovy and Ozempic contain the exact same drug: semaglutide, made by Novo Nordisk. The differences come down to three things:
Dose: Ozempic tops out at 2 mg per week. Wegovy goes up to 2.4 mg per week, which is the dose studied in the major weight loss trials.
Approved indication: Ozempic is approved by Health Canada for type 2 diabetes. Wegovy is approved for chronic weight management. This distinction matters for insurance coverage and how your doctor prescribes it.
Titration schedule: Wegovy uses a 5-step dose escalation over 16 weeks. Ozempic has a simpler 3-step titration since the target doses are lower.
From a molecular standpoint, there is zero difference. Your body cannot tell them apart. The reason Novo Nordisk sells them as separate products is regulatory and commercial. Because Ozempic is widely prescribed off-label for weight loss with better insurance coverage for diabetes, some Canadian doctors prescribe Ozempic at higher doses as a workaround during Wegovy supply shortages.
The STEP Trial Results: Real Weight Loss Numbers
Wegovy's approval was based on the STEP (Semaglutide Treatment Effect in People with obesity) trial program. These were large, randomized, double-blind, placebo-controlled trials. Here are the headline numbers:
| Trial | Participants | Duration | Wegovy Weight Loss | Placebo Weight Loss |
|---|---|---|---|---|
| STEP 1 | 1,961 adults without diabetes | 68 weeks | 14.9% | 2.4% |
| STEP 2 | 1,210 adults with type 2 diabetes | 68 weeks | 9.6% | 3.4% |
| STEP 3 | 611 adults + intensive behavioural therapy | 68 weeks | 16.0% | 5.7% |
| STEP 4 | 902 adults (continuation vs. placebo switch) | 68 weeks | Continued losing | Regained 2/3 |
| STEP 5 | 304 adults | 104 weeks | 15.2% | 2.6% |
In STEP 1, the average starting weight was about 105 kg (231 lbs). A 14.9% loss means roughly 15.6 kg (34.4 lbs) over 68 weeks. About 32% of participants lost 20% or more of their body weight, while some lost less than 5%. STEP 3 combined Wegovy with intensive behavioural therapy and achieved 16% average loss, suggesting lifestyle changes on top of the medication lead to better outcomes.
STEP 4 answered the crucial question: what happens if you stop? After 20 weeks on semaglutide, participants who switched to placebo regained about two-thirds of their weight loss over the following 48 weeks. This tells us that Wegovy is likely a long-term commitment for sustained results.
The SELECT trial (17,604 participants with overweight/obesity and cardiovascular disease but without diabetes) showed that semaglutide 2.4 mg reduced major cardiovascular events by 20%. This was the first time any weight management drug demonstrated direct heart protection.
Wegovy Dosing: The 5-Step Titration Schedule
Wegovy uses a gradual dose escalation to minimize side effects, especially nausea. You do not start at the full dose. Here is the standard schedule:
| Month | Dose | Duration |
|---|---|---|
| Month 1 | 0.25 mg weekly | 4 weeks |
| Month 2 | 0.5 mg weekly | 4 weeks |
| Month 3 | 1.0 mg weekly | 4 weeks |
| Month 4 | 1.7 mg weekly | 4 weeks |
| Month 5 onward | 2.4 mg weekly (maintenance) | Ongoing |
Each dose comes in a separate pre-filled pen. You inject once per week, on the same day each week, at any time of day, with or without food. The injection goes into your abdomen, thigh, or upper arm, and you rotate sites. Not everyone reaches 2.4 mg. Some patients find that 1.7 mg gives them sufficient appetite suppression with fewer side effects.
If you miss a dose by more than 5 days, take it as soon as possible and resume your regular schedule. If more than 5 days have passed, skip that week and take the next scheduled dose. Do not double up.
Who Qualifies for Wegovy in Canada?
Health Canada approved Wegovy for adults (18 years and older) who meet one of these criteria: BMI of 30 or greater (obesity), or BMI of 27 or greater (overweight) with at least one weight-related health condition such as type 2 diabetes, high blood pressure, dyslipidemia, or obstructive sleep apnea.
Wegovy is not appropriate for patients with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia type 2, or a history of pancreatitis. It must be stopped at least 2 months before a planned pregnancy. In practice, most Canadian doctors focus on your metabolic health picture rather than BMI alone.
What to Expect Month by Month
Weeks 1 to 4 (0.25 mg): Most patients notice reduced appetite within the first week or two. Weight loss is modest, typically 1 to 2 kg. Nausea is common but usually mild.
Weeks 5 to 8 (0.5 mg): Appetite suppression becomes more noticeable. You may find you cannot finish meals you used to eat easily. Some patients report changes in food preferences, finding greasy or very sweet foods less appealing.
Weeks 9 to 12 (1.0 mg): This is where many patients see significant momentum. Weight loss typically accelerates. GI side effects may return briefly with each dose increase but tend to settle within 1 to 2 weeks.
Weeks 13 to 16 (1.7 mg): Approaching the maintenance dose range. Most patients have lost 5% to 8% of their starting weight by this point.
Week 17 onward (2.4 mg): The full dose. Weight loss continues gradually. Most of the total weight loss occurs in the first 9 to 12 months. After 12 months, weight tends to plateau and the focus shifts to maintenance.
Individual variation is significant. Some people lose 20% or more of their body weight. Others plateau at 8% to 10%. Response at the 3-month mark is often a good predictor of long-term results.
Side Effects Overview
The most common issues are gastrointestinal: nausea (about 44%), diarrhea (30%), vomiting (24%), and constipation (24%). These are typically worst during dose escalation and improve once you reach your maintenance dose. Serious but rare side effects include pancreatitis, gallbladder problems, and potential thyroid concerns.
Read the full guide: Ozempic Side Effects: What Canadian Patients Need to Know
Cost Overview
Wegovy is not cheap. Without insurance, you are looking at roughly $400 to $500 per month in Canada. Insurance coverage for weight management medications remains limited. Most provincial formularies do not cover Wegovy yet, and private insurer coverage varies widely.
Read the full guide: Wegovy Cost in Canada: Pricing, Insurance, and Savings
Generic Semaglutide at In-Person Canadian Pharmacies
Cash retail prices for generic semaglutide at Canadian pharmacies are now coming in below the telehealth alternatives, based on early Canadian consumer reports. Costco Pharmacy is the lowest reliable option at roughly $88 to $99 per month (confirmed pickups: $88.88 GTA, $88 Ontario, $99 Laval, $91 Medicine Hat). Walmart and Loblaws No Frills typically come in around $95 to $110 per month. Shoppers Drug Mart, Rexall and London Drugs are running roughly $100 to $120 per month (one Halifax-area Shoppers fill reported $113 for the 0.25mg starter dose). Apotex's Apo-Semaglutide Injection began shipping to Canadian pharmacies on May 20, 2026, with Dr. Reddy's generic also launching in May 2026.
That makes in-person pharmacies — especially Costco — meaningfully cheaper than telehealth providers for generic semaglutide. Felix Health and Hims Canada both list $149 per month all-in for the same generic Apo-Semaglutide on their public pricing pages. For most Canadians with a valid prescription, walking it into a local pharmacy is now the cheapest reliable path.
Pricing context: per the Globe and Mail, Apotex's published wholesale price is $78.14 for a four-week supply — roughly one-third of brand-name Ozempic's $240.48 wholesale price. Retail estimates above reflect that wholesale plus each chain's standard dispensing fee and markup. See also coverage from CBC News on the Canadian launch. Note: The May 2026 generic launch covers the Ozempic indication for type 2 diabetes only. Generic Wegovy (semaglutide 2.4 mg for chronic weight management) is not yet available — Novo Nordisk holds additional patents on the high-dose formulation. Under the pan-Canadian Pharmaceutical Alliance framework, the maximum public drug plan price for generic semaglutide is approximately $114 per four-week supply with two manufacturers approved, dropping to roughly $80 once a third manufacturer launches.
How to Get Wegovy
Getting Wegovy requires a prescription from a Canadian physician or nurse practitioner. Your doctor will assess your eligibility based on BMI and weight-related conditions, discuss benefits and risks, and start you on the titration schedule. There are now several virtual care platforms offering Wegovy prescriptions across provinces alongside traditional in-person options.
Read the full guide: How to Get Wegovy in Canada: Complete Step-by-Step Guide
Wegovy vs Mounjaro: Which Is More Effective?
This is the question everyone is asking in 2026. Mounjaro (tirzepatide) works on two receptors (GIP and GLP-1) compared to Wegovy's single GLP-1 mechanism. In head-to-head adjacent comparisons:
| Metric | Wegovy (Semaglutide 2.4 mg) | Mounjaro (Tirzepatide 15 mg) |
|---|---|---|
| Average weight loss | 15% to 16% | 20% to 22% |
| Patients losing 20%+ | About 32% | About 57% |
| Mechanism | GLP-1 only | GIP + GLP-1 dual agonist |
| Cardiovascular data | SELECT: 20% MACE reduction | SURPASS-CVOT ongoing |
On pure weight loss numbers, Mounjaro has an edge. But Wegovy has the SELECT cardiovascular outcomes data showing a 20% reduction in heart events. Mounjaro does not yet have equivalent data. For patients with cardiovascular risk, Wegovy currently has stronger evidence for heart protection. Your doctor will help you weigh these trade-offs.
Learn more: Mounjaro in Canada: The Complete Guide
Online Providers Cost Comparison
Most Canadians now access Wegovy through telehealth providers rather than in-person clinics. Below is how the main Canadian online providers compare for Wegovy prescribing, with MyRocky now our highest-rated GLP-1 provider overall.
| Provider | Wegovy Monthly Cost | Consultation Fee | Coverage | Learn More |
|---|---|---|---|---|
| MyRocky | Contact for current availability | $99 one-time (includes lab work and first prescription) | All 10 provinces (including QC and NB) | Visit MyRocky |
| Felix Health | $500 to $570 | Free (first), $40 follow-up | All provinces except QC and NB | Visit Felix |
| Maple | $500 to $570 | $69 one-time | All provinces + territories | Visit Maple |
| Hims Canada | Generic semaglutide available — pricing on consult | Included in plan | ON, BC, AB (expanding 2026) | Visit Hims |
| Jill Health | Pricing on assessment | Pricing on assessment | Select provinces | Visit Jill |
| Raven | Pricing on assessment | Pricing on assessment | 9 provinces | Visit Raven |
MyRocky is our highest-rated Canadian GLP-1 telehealth provider in 2026 (9.4/10). MyRocky operates its own LegitScript-certified pharmacy in Mississauga, employs Canadian-licensed MDs, nurse practitioners and pharmacists, and serves all 10 provinces (including Quebec and New Brunswick where Felix and Hims do not). The $99 one-time consultation includes lab work and the first prescription. Read our full MyRocky review.
FAQ
Is Wegovy available in Canada right now? Yes, Wegovy is approved and available, though supply has fluctuated since launch. As of early 2026, availability has improved significantly.
Can I use Ozempic instead of Wegovy for weight loss? Many doctors prescribe Ozempic off-label for weight management when Wegovy is unavailable or when insurance only covers Ozempic for a diabetes diagnosis. The drug is identical, but Ozempic's maximum dose (2 mg) is lower than Wegovy's (2.4 mg).
How long do I need to take Wegovy? Current evidence supports long-term use. Stopping leads to weight regain in most patients, as shown in STEP 4. Think of it like blood pressure medication. It works while you take it.
Will I feel hungry on Wegovy? Most patients report a dramatic reduction in appetite and food noise (the constant background thinking about food). This is one of the most commonly reported benefits beyond the scale.
Can I drink alcohol on Wegovy? There is no absolute contraindication, but many patients find their alcohol tolerance decreases. Semaglutide slows gastric emptying, which can change how quickly alcohol is absorbed. Most doctors recommend moderating intake.
What if Wegovy does not work for me? If you have not achieved at least 5% weight loss after 16 to 20 weeks on the maintenance dose, your doctor will reassess. Options include adding lifestyle interventions, switching to tirzepatide (Mounjaro), or exploring other approaches.
Sources
- Wilding JPH, et al. NEJM. 2021;384(11):989-1002. (STEP 1)
- Davies M, et al. The Lancet. 2021;397(10278):971-984. (STEP 2)
- Wadden TA, et al. JAMA. 2021;325(14):1403-1413. (STEP 3)
- Rubino D, et al. JAMA. 2021;325(14):1414-1425. (STEP 4)
- Garvey WT, et al. Nature Medicine. 2022;28:2083-2091. (STEP 5)
- Lincoff AM, et al. NEJM. 2023;389(24):2221-2232. (SELECT)
- Novo Nordisk. Wegovy (semaglutide) Canadian Product Monograph. Health Canada.
- Obesity Canada. 2024 Clinical Practice Guidelines for Obesity Management.